2019 logo_150x35_jpg.jpg
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
08 mai 2023 09h05 HE | Novan, Inc.
DURHAM, N.C., May 08, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its first quarter 2023 financial results on Monday, May...
2019 logo_150x35_jpg.jpg
Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹
27 avr. 2023 09h10 HE | Novan, Inc.
Published results from a National Psoriasis Foundation-fielded survey included responses from more than 400 patients across US1 Findings highlight impact on patient adherence of early onset of...
logo_001.png
Brooge Energy Reports 2022 Revenue of USD $81.5 Million, an Increase of 95% Year-Over-Year, and Provides Outlook for 2023
26 avr. 2023 16h45 HE | Brooge Energy Limited
Management is providing revenue guidance for 2023 of over USD $125 million Management will host a conference call on Thursday, May 4th at 10 a.m. ET NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) --...
2019 logo_150x35_jpg.jpg
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
20 avr. 2023 09h00 HE | Novan, Inc.
DURHAM, N.C., April 20, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host an Analyst and Investor Event: A Discussion of Molluscum’s...
Notified-Color-Large.jpg
GlobeNewswire, Notified’s Newswire Distribution Network, Distributed a Record Number of Press Releases in 2022, Resulting in a 16% Increase Over the Last Two Years
11 avr. 2023 09h15 HE | Notified
NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- Notified, a globally-trusted technology partner for public relations, investor relations, and marketing professionals today announced that GlobeNewswire...
2019 logo_150x35_jpg.jpg
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
30 mars 2023 06h30 HE | Novan, Inc.
– Berdazimer gel, 10.3% (SB206) assigned PDUFA goal date of January 5, 2024 – – Strong year-over-year prescription growth across three promoted products, RHOFADE, WYNZORA and MINOLIRA – – Company...
2019 logo_150x35_jpg.jpg
Novan to Report Full Year 2022 Financial Results on March 30, 2023
23 mars 2023 09h00 HE | Novan, Inc.
DURHAM, N.C., March 23, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2022 financial results on Thursday,...
Tekumo Adding Three Development Team Leads for Core Product Offering
20 mars 2023 10h07 HE | Balincan USA, Inc.
New York , March 20, 2023 (GLOBE NEWSWIRE) -- Balincan USA Inc. (OTC: BCNN, TKMO pending FINRA approval, "Balincan '' or the "Company") today announced the hiring of three new engineers to lead...
2019 logo_150x35_jpg.jpg
Novan Announces Closing of $6.0 Million Registered Direct Offering
16 mars 2023 16h15 HE | Novan, Inc.
DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the closing of the issuance and sale in the Company’s previously announced...
2019 logo_150x35_jpg.jpg
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
14 mars 2023 08h30 HE | Novan, Inc.
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...